Picture of Greenlight Biosciences Holdings PBC logo

GRNA — Greenlight Biosciences Holdings PBC News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Brief: Greenlight Biosciences Announces Third Quarter 2022 Financial Results

Nov 9 (Reuters) - Greenlight Biosciences Holdings PBC
 GRNA.O :
    * GREENLIGHT BIOSCIENCES ANNOUNCES THIRD QUARTER 2022
FINANCIAL
RESULTS AND HIGHLIGHTS RECENT COMPANY PROGRESS
    * GREENLIGHT BIOSCIENCES HOLDINGS PBC- CASH, CASH
EQUIVALENTS, AND
MARKETABLE SECURITIES WERE $98.4 MILLION AS OF SEPTEMBER 30,
2022
    * GREENLIGHT BIOSCIENCES HOLDINGS PBC - QTRLY NET LOSS PER
SHARE -
BASIC AND DILUTED $0.27

Source text for Eikon:  ID:nGNXbb0x9H 
Further company coverage:  GRNA.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Greenlight Biosciences Holdings PBC

See all news